BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21665181)

  • 1. The effect of TP53 codon 72 and RNASEL codon 462 polymorphisms on the development of cervical cancer in Argentine women.
    Barbisan G; Contreras A; Pérez LO; Difranza L; Golijow CD
    Cancer Genet; 2011 May; 204(5):270-7. PubMed ID: 21665181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer.
    Santos AM; Sousa H; Pinto D; Portela C; Pereira D; Catarino R; Duarte I; Lopes C; Medeiros R
    Eur J Cancer; 2006 May; 42(7):958-63. PubMed ID: 16542834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
    Jiang P; Liu J; Zeng X; Li W; Tang J
    Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
    Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
    Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
    Bhattacharya P; Sengupta S
    Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the polymorphisms in the exons 2 to 4 of the TP53 in cervical carcinoma patients from a Brazilian population.
    Fernandes TA; Lima GL; De Souza FC; Fernandes JV; Meissner RV
    Cell Mol Biol (Noisy-le-grand); 2008 Jun; 54 Suppl():OL1025-31. PubMed ID: 18954551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 codon 72 polymorphism and risk for cervical cancer in Portugal.
    Santos AM; Sousa H; Catarino R; Pinto D; Pereira D; Vasconcelos A; Matos A; Lopes C; Medeiros R
    Cancer Genet Cytogenet; 2005 Jun; 159(2):143-7. PubMed ID: 15899386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women.
    Lee SA; Kim JW; Roh JW; Choi JY; Lee KM; Yoo KY; Song YS; Kang D
    Gynecol Oncol; 2004 Apr; 93(1):14-8. PubMed ID: 15047208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
    Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
    Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
    Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
    Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population.
    Sameer AS; Shah ZA; Syeed N; Banday MZ; Bashir SM; Bhat BA; Siddiqi MA
    Genet Mol Res; 2010 Apr; 9(2):651-60. PubMed ID: 20449797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.
    Jha P; Jha P; Pathak P; Chosdol K; Suri V; Sharma MC; Kumar G; Singh M; Mahapatra AK; Sarkar C
    Exp Mol Pathol; 2011 Apr; 90(2):167-72. PubMed ID: 21115003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
    Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
    Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 polymorphism, HPV infection, and risk of cervical cancer.
    Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer.
    Dokianakis DN; Spandidos DA
    Mol Cell Biol Res Commun; 2000 Feb; 3(2):111-4. PubMed ID: 10775508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
    Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population.
    Pandith AA; Shah ZA; Khan NP; Rasool R; Afroze D; Yousuf A; Wani S; Siddiqi M
    Cancer Genet Cytogenet; 2010 Dec; 203(2):263-8. PubMed ID: 21156242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.